Overview of the Ataxias
Non-specific pharmacological agents of potential benefit include amantadine, alpha-lipoic acid, buspirone, branchedchain amino acids, creatine, coenzyme Q10, vitamin E, physostigmine, riluzole, and selective serotonin reuptake inhibitors.
Non-specific pharmacological agents of potential benefit include amantadine, alpha-lipoic acid, buspirone, branchedchain amino acids, creatine, coenzyme Q10, vitamin E, physostigmine, riluzole, and selective serotonin reuptake inhibitors.